US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

243.08

+1.650.68%

Number of Gainers:13

Number of Losers:2

Number of Flat:2

PE:- -

High:243.17

Open:241.47

Low:239.00

Close:241.43

Volume:6.54M

Turnover:61.35M

Market Cap:58.61B

Float Cap:52.80B

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading

MT Newswires Live

Cronos Group Inc expected to post earnings of 1 cent a share - Earnings Preview

Cronos Group initiated with a Buy at TD Securities

Has Teva (TEVA) Run Too Far After Its 102% One-Year Share Price Surge?

Simply Wall St.

FDA approves Amphastar’s Ipratropium Bromide HFA inhalation aerosol ANDA

Dr. Reddy's Laboratories Slips Tuesday, Underperforms Competitors

Mercia Asset Management Continues Share Buyback With Further AIM Purchase

Cathie Wood’s ARK Investment buys 667K shares of Aurora Innovation today

Aurora Acquisition Signs Warrant and Registration Agreements

Asian Equities Traded in the US as American Depositary Receipts Start Week Slightly Higher in Monday Trading

MT Newswires Live

AIM announces planned milestones in Phase 2 trial of Ampligen, Durvalumab

AIM ImmunoTech Inc. Makes Updated Corporate Presentation Available

FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application

Harrow (HROW) Valuation Check As PharmaPack Launch Targets Cataract Surgery Market

Simply Wall St.

Aurora UK Alpha Affirms MAR Compliance and Trading Ability in Closed Period

Nelson Resources Relocates Registered Office to Perth CBD

Teva Pharmaceutical Says FDA Accepts New Drug Application for Olanzapine in Schizophrenia Treatment

MT Newswires Live

FDA accepts Teva NDA for olanzapine extended-release injectable suspension

Dr. Reddy's Secures FDA Review for Abatacept Biologics License Application

MT Newswires Live

Aurora Innovation Years Ahead of Competitors, Oppenheimer Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4557/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":243.08046,"timestamp":1771950071194,"preClose":241.43008,"halted":0,"volume":6536516,"delay":0,"changeRate":0.006836,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":1.650375,"latestTime":"02-24 11:21:12 EST","open":241.46947,"high":243.16922,"low":238.99582,"amount":61352372.35682,"amplitude":0.017286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.303455,"peRate":-148.603792,"turnoverRate":0.002238,"increases":13,"decrements":2,"flats":1,"marketCap":58610896288.5,"floatMarketCap":52797819472.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":243.16922,"amplitude":0.017286,"preClose":241.43008,"low":238.99582,"pbRate":"3.303455","latestPrice":243.08046,"volume":6536502,"delay":0,"open":241.46947,"prevYearClose":226.48174,"prevWeekClose":243.013,"prevMonthClose":237.0625,"prevQuarterClose":226.4817,"fiveDayClose":242.9786,"twentyDayClose":229.6729,"sixtyDayClose":165.1995,"secType":"PLATE","market":"US","turnoverRate":0.002238,"peRate":-148.603792,"marketCap":58609437132.5,"floatMarketCap":52796411136.5,"timestamp":1771950070137,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":13,"down":2,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613743923","title":"Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2613743923","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613743923?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:36","pubTimestamp":1771947419,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking modestly higher Tuesday morning, rising 0.15% to 2,965.64 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by internet and data center services provider VNET Group  and online game developer The9 , which climbed 12% and 6.2% respectively. They were followed by semiconductor company ASE Technology  and computer hardware maker Canaan , which advanced 6% and 5.2% respectively.The decliners from North Asia were led by consumer lender Eason Technology  and game live-streaming service DouYu International , which lost 7.7% and 4.2% respectively. They were followed by game live-streaming service HUYA  and pet-focused platform Boqii , which fell 3.5% and 3.4% respectively.From South Asia, the gainers were led by IT firm Sify Technologies , which rose 9%, followed by telecommunications operator PLDT  and pharmaceutical company Dr. Reddy's Laboratories , which were up 0.7% and 0.1% respectively.The dec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999002414.USD","BK4164","BK4220","BK4596","LU0589944569.HKD","LU0572940350.SGD","LU1102505929.USD","SG9999004360.SGD","LU0516422440.USD","BK4117","LU0261945553.USD","IBN","LU2065170008.USD","LU0572939691.SGD","LU0066902890.USD","LU0287143357.SGD","LU0918141705.HKD","SG9999002604.SGD","LU2045819591.USD","LU1854103824.USD","BK4523","BK4600","LU1868837722.USD","LU0348744763.USD","BK4503","LU0231203729.USD","SG9999013486.USD","BK4535","BK4513","LU0248272758.USD","LU0143863198.USD","LU1242518857.USD","IE0034224299.USD","LU2065169927.USD","BK4132","LU0390134368.USD","LU2226246903.HKD","IE00BYTNYM70.SGD","LU1868838027.USD","VNET","LU0307460401.USD","LU0345775950.USD","LU0251143029.SGD","SG9999002620.SGD","LU0348788117.USD","LU2152927971.USD","LU0823038988.USD","LU0516422952.EUR","LU0823039010.USD","LU1282648689.USD","SG9999013478.USD","LU0348814723.USD","NCTY","LU1267930656.SGD","HDB","LU0289960550.SGD","SG9999014013.SGD","LU2238330802.EUR","SG9999002679.SGD","BK4116","BK4543","LU0797268264.HKD","LU1242518931.SGD","LU0431992006.USD","LU2177674079.SGD","IE00B0JY6M65.USD","BK4585","CAN","BK4200","BK7016","LU0499858602.USD","SE","LU1791710582.SGD","BK4023","LU0541502299.USD","LU0072462343.USD","BK4007","RDY","SIFY","LU0164881194.USD","LU1048596156.SGD","LU0264410563.USD","LU0737861269.HKD","BK4107","LU0197773673.USD","LU0541501648.USD","LU0261950470.USD","LU1508157978.USD","LU0516423091.SGD","LU1805238398.USD","BK4085","LU0630378429.USD","SG9999006266.SGD","LU0708995666.HKD","BK7502","BK4577","LU1868837565.USD","LU0828237940.HKD","WIT","LU0441851309.USD","LU0345776255.USD","BQ","BK7508","IE0031814969.USD","LU1854104046.USD","SG9999013460.SGD","BK4554","LU0264606111.USD","BK4607","LU0528227936.USD","DXF","BK4526","BK4531","LU1046422090.SGD","ASX","LU0456842615.SGD","PHI","SG9999005177.SGD","IE00B7N09G41.SGD","LU2008162690.USD","SG9999014492.USD","LU1102505762.USD","BK4509","LU1105468828.SGD","LU0197229882.USD","LU1839390173.USD","LU2065171311.SGD","BK4557","LU0048573645.USD","SG9999001135.SGD","BK4588","IE00BD6J9T35.USD","SGXZ58947870.SGD","LU1861217088.USD","LU0516422366.SGD","BK4566","LU0499858438.USD","LU1770036033.HKD","BK4548","BK4089","LU0048575426.USD","LU2543165471.USD","LU0175139822.USD","LU1804176565.USD","LU0821914370.USD","BK4122","LU0536402901.SGD","LU0516423174.USD","BK4581","LU0348816934.USD","SG9999014005.SGD","LU1481012133.USD","LU0868486357.SGD","HUYA","LU2065171402.SGD","LU2279701549.SGD","BK7096","LU0143863784.USD","LU0630378692.HKD","LU1861220207.SGD","LU2125910849.SGD","SG9999014021.USD","LU0531971678.HKD","LU0979878070.USD","SG9999002406.SGD","BK4170","SG9999014484.SGD","BK4595","LU2265009873.SGD","BK4141","BK4551","LU0251143458.SGD","LU0918141887.USD","LU1048588211.SGD","LU0532188223.SGD","BK4532","LU1791710400.SGD","LU2360107671.USD","SG9999004220.SGD","IE0001KFT4U8.USD","LU0197773160.USD","SG9999014039.USD","LU0210637038.USD","LU0181495838.USD","DOYU","LU2125910500.SGD","BK7039","BK4134","BK4207","LU2663582299.SGD"],"gpt_icon":1},{"id":"2613710336","title":"Cronos Group Inc  expected to post earnings of 1 cent a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2613710336","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613710336?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:25","pubTimestamp":1771943109,"startTime":"0","endTime":"0","summary":"Cronos Group Inc  expected to post earnings of 1cent a share - Earnings Preview Cronos Group Inc CRON.TO  is expected to  show a rise in quarterly revenue when it reports  results on February 26 for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL8N3ZK1NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRON","BK4557"],"gpt_icon":0},{"id":"2613191717","title":"Cronos Group initiated with a Buy at TD Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2613191717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613191717?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:39","pubTimestamp":1771936787,"startTime":"0","endTime":"0","summary":"TD Securities initiated coverage of Cronos Group (CRON) with a Buy rating and C$4.50 price target Cronos, which has “some of the most iconic Canadi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cronos-group-initiated-with-a-buy-at-td-securities-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cronos-group-initiated-with-a-buy-at-td-securities-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","TD","BK4007","BK4585","BK4207","BK4566","CRON"],"gpt_icon":0},{"id":"2613571632","title":"Has Teva (TEVA) Run Too Far After Its 102% One-Year Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2613571632","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613571632?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:22","pubTimestamp":1771932123,"startTime":"0","endTime":"0","summary":"If you are wondering whether Teva Pharmaceutical Industries is still good value after its recent run, this article walks through what the current share price might be implying about the company.\nTeva's share price last closed at US$33.91, with returns of 6.6% over the past 30 days, 9.6% year to date and 102.1% over the last year. The 3 year and 5 year returns sit at 242.5% and 210.5% respectively, which raises the question of how much optimism is already reflected in the price.\nRecent...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/has-teva-teva-run-too-far-after-its-102-one-year-share-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/has-teva-teva-run-too-far-after-its-102-one-year-share-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","BK4559","DCF","LU1983299246.USD","BK4566","LU2324357040.USD","BK4007","BK4596","BK4584","TEVA","BK4557"],"gpt_icon":0},{"id":"2613671790","title":"FDA approves Amphastar’s Ipratropium Bromide HFA inhalation aerosol ANDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2613671790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613671790?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:00","pubTimestamp":1771930823,"startTime":"0","endTime":"0","summary":"Amphastar Pharmaceuticals Inc. said the U.S. Food and Drug Administration approved its Abbreviated New Drug Application for Ipratropium Bromide HFA Inhalation Aerosol 17 mcg/actuation. The FDA determined the product is bioequivalent and therapeutically equivalent to Boehringer Ingelheim’s Atrovent HFA, and confirmed Amphastar is eligible for 180 days of generic drug exclusivity starting on the first day of commercial launch.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL8MqZ8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH","BK4588","BK4557","BK4007","BK4585"],"gpt_icon":0},{"id":"2613927237","title":"Dr. Reddy's Laboratories Slips Tuesday, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613927237?lang=en_us&edition=fundamental","pubTime":"2026-02-24 18:30","pubTimestamp":1771929000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Dr. Reddy's Laboratories Ltd.  shares inched down 0.58% to 1,299.40 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index  falling 1.28% to 82,225.92.Dr. Reddy's Laboratories Ltd. closed 5.70% below its 52-week high of 1,377.95 rupees, which the company reached on June 12th.The stock underperformed when compared to some of its competitors Tuesday, as Lupin Ltd.  rose 0.39% and Zydus Lifesciences Ltd.  fell 0.45%. Wockhardt Ltd.  fell 0.21%.Trading volume totaled 46,287, compared to the 50-day average of 95,171.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","RDY","BK4007","LU0348744763.USD","BK4523","BK4532","BK4557"],"gpt_icon":0},{"id":"2613746760","title":"Mercia Asset Management Continues Share Buyback With Further AIM Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2613746760","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613746760?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:32","pubTimestamp":1771918353,"startTime":"0","endTime":"0","summary":"Mercia Asset Management ( ($GB:MERC) ) has provided an update. Mercia Asset Management has repurchased 20,000 ordinary shares at 29.25 pence each o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mercia-asset-management-continues-share-buyback-with-further-aim-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mercia-asset-management-continues-share-buyback-with-further-aim-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AIM","BK4557"],"gpt_icon":0},{"id":"2613752576","title":"Cathie Wood’s ARK Investment buys 667K shares of Aurora Innovation today","url":"https://stock-news.laohu8.com/highlight/detail?id=2613752576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613752576?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:15","pubTimestamp":1771895753,"startTime":"0","endTime":"0","summary":"20:10 EST Cathie Wood’s ARK Investment buys 667K shares of Aurora Innovation (AUR) today Published first on TheFly – the ultimate source for real-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-667k-shares-of-aurora-innovation-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-667k-shares-of-aurora-innovation-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4588","BK4557","ACB","BK4007","ARKQ","BK4585","BK4137","ARKK","MSOS","BK4023","AUR","BK4544"],"gpt_icon":0},{"id":"2613555047","title":"Aurora Acquisition Signs Warrant and Registration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2613555047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613555047?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:51","pubTimestamp":1771887074,"startTime":"0","endTime":"0","summary":"Aurora Acquisition ( ($BETR) ) has issued an announcement. On February 17, 2026, Better Home & Finance Holding Company entered into a Securities Pu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-acquisition-signs-warrant-and-registration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-acquisition-signs-warrant-and-registration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4557","MSOS","ACB"],"gpt_icon":0},{"id":"2613733343","title":"Asian Equities Traded in the US as American Depositary Receipts Start Week Slightly Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2613733343","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613733343?lang=en_us&edition=fundamental","pubTime":"2026-02-23 23:35","pubTimestamp":1771860957,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts opened the week modestly higher Monday morning, rising 0.10% to 2,989.81 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by electric vehicle maker NIO  and thin-film liquid display maker LG Display , which advanced 5.7% and 3.6%, respectively. They were followed by online game developer The9  and healthcare platform 111 , which increased 3.5% and 2.7,% respectively.The decliners from North Asia were led by automotive marketplace Cango  and computer hardware Canaan , which dropped 7% and 5.5,% respectively. They were followed by fintech firm Jiayin Group  and travel company Tuniu , which lost 2.7% and 1.6% respectively.From South Asia, the gainers were led by telecommunications operators Telekomunikasi Indonesia  and PLDT , which rose 1.6% each. They were followed by pharmaceutical company Dr. Reddy's Laboratories  and lender HDFC Bank , which were up 1.2% and 0.7%, respectively.The decliners from South A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4509","LU0918141705.HKD","LU1861220207.SGD","BK4505","LU0348816934.USD","LU0918141887.USD","BK4523","LU0979878070.USD","LU0868486357.SGD","LU1323998911.USD","LU0791590937.USD","NCTY","LU0516422366.SGD","CAN","NIO.SI","LU0823039010.USD","LU0289960550.SGD","LU0516422440.USD","BK7508","LU0541501648.USD","BK4132","LU2045819591.USD","BK4128","LU1805238398.USD","LU0197773160.USD","BK4526","LU0251143029.SGD","BK4122","IE00B3M56506.USD","SG9999014039.USD","LU0589944569.HKD","LU0572939691.SGD","BK4535","TOUR","SG9999013478.USD","BK4220","LU2065171311.SGD","LU0348788117.USD","BK4134","LU1854103824.USD","BK4574","LU2087589342.USD","BK4595","BK7096","BK4518","BK4207","LU0066902890.USD","LU0210637038.USD","IE0001KFT4U8.USD","BK4503","IE0034224299.USD","LU2125910849.SGD","BK4581","LU0231203729.USD","JFIN","LU2065170008.USD","LU0862451753.SGD","LU0898667661.SGD","TLK","LU1839390173.USD","BK4115","BK4214","HDB","LU1242518931.SGD","LU1366334578.USD","LU0541502299.USD","PHI","LU0797268264.HKD","BK4533","LU0572940350.SGD","LU0791591158.USD","SG9999014484.SGD","LU0052750758.USD","BK4142","LU0345776255.USD","LU0456842615.SGD","RDY","09866","LU0264606111.USD","LU1861217088.USD","SG9999013460.SGD","LU0164881194.USD","BK4085","WIT","LU1508157978.USD","LU2152927971.USD","IE00BYTNYM70.SGD","LU0175139822.USD","BK4170","BK4588","BK7016","LU0630378429.USD","LU0708995666.HKD","LU1804176565.USD","LU2543165471.USD","YI","IE00BD6J9T35.USD","BK4532","LU2125910500.SGD","BK4148","LU0499858438.USD","SG9999014005.SGD","LU2065169927.USD","BK4117","LU2265009873.SGD","LU0348814723.USD","BK4548","LU0531971678.HKD","SG9999002414.USD","LU0528227936.USD","LU0441851309.USD","LU1105468828.SGD","LU0072462343.USD","LU0307460401.USD","LU0516422952.EUR","LU1791710582.SGD","LU2238330802.EUR","INFY","BK4596","LU0737861269.HKD","SG9999001135.SGD","BK4585","BK4504","LU1242518857.USD","SG9999002406.SGD","IE0031814969.USD","SG9999002620.SGD","LU0532188223.SGD","BK4600","LU1366334651.USD","LU2008162690.USD","LU0536402901.SGD","SG9999004360.SGD","BK4577","BK4534","LU0630378692.HKD","LU0516423091.SGD","LU1048588211.SGD","IE00B7N09G41.SGD","LU2279701549.SGD","LU2226246903.HKD","LU0197229882.USD","LU0708995583.HKD","BK4023","SG9999014492.USD","LU0345775950.USD","LU2663582299.SGD","SIFY","CANG","LU0823038988.USD","BK4107","NIOG","BK4555","BK4531","SG9999005177.SGD","LU0431992006.USD","BK4557","SG9999006266.SGD","SG9999014013.SGD","LU0499858602.USD","NIO","BK4099","BK4007","LU0261945553.USD","SG9999014021.USD","LU1854104046.USD","LU0333810181.USD","BK7502","SGXZ58947870.SGD","SG9999002679.SGD","LU0320764599.SGD","LU0287143357.SGD","LU0890818403.SGD","BK4554","LU1267930656.SGD","LU0390134368.USD","EVS.SI","LU2065171402.SGD","BK4166","LU0831103253.SGD","LU2177674079.SGD","LU0048573645.USD","LU0197773673.USD","SE","SG9999002604.SGD","SG9999013486.USD","BK4566","LU0348744763.USD","BK4089","BK4551","LU1770036033.HKD","LU1791710400.SGD","LU2360107671.USD","LU0516423174.USD","IE00B0JY6M65.USD","LU1102505762.USD","LPL","LU1282648689.USD"],"gpt_icon":1},{"id":"2613780616","title":"AIM announces planned milestones in Phase 2 trial of Ampligen, Durvalumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2613780616","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613780616?lang=en_us&edition=fundamental","pubTime":"2026-02-23 22:07","pubTimestamp":1771855625,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech (AIM) announced milestones in the expected timeline for the ongoing Phase 2 clinical study evaluating AIM’s drug Ampligen combined w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aim-announces-planned-milestones-in-phase-2-trial-of-ampligen-durvalumab-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aim-announces-planned-milestones-in-phase-2-trial-of-ampligen-durvalumab-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AIM","BK4557"],"gpt_icon":0},{"id":"2613787920","title":"AIM ImmunoTech Inc. Makes Updated Corporate Presentation Available","url":"https://stock-news.laohu8.com/highlight/detail?id=2613787920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613787920?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:55","pubTimestamp":1771854918,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. said it has published an updated corporate presentation on its website titled “Ampligen Breakthroughs in Treating Late-Stage Pancreatic Cancer: Corporate Presentation - February 2026.” The document is available at Ampligen Breakthroughs in Treating Late-Stage Pancreatic Cancer: Corporate Presentation - February 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AIM ImmunoTech Inc. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL59wf4m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","NDAQ","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4588","AIM","SG9999014021.USD","LU2095319765.USD","SG9999014039.USD","BK4557","IE00B64PRP62.GBP","SG9999014005.SGD","BK4139","SG9999014013.SGD","IE00BKPKM429.USD","LU2210150020.SGD","BK4585","BK4112"],"gpt_icon":0},{"id":"2613480787","title":"FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2613480787","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613480787?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:48","pubTimestamp":1771854480,"startTime":"0","endTime":"0","summary":"Teva Pharmaceuticals Industries Ltd  on Friday announced that the U.S. Food and Drug Administration  has accepted its New Drug Application  for olanzapine extended-release injectable suspension.The marketing application for TEV-‘749 is based on results from the Phase 3 SOLARIS trial, which demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations.This investigational drug aims to improve treatment adherence for individuals living with schizophrenia, addressing a critical gap in care.In the SOLARIS trial, TEV-‘749 was administered as a once-monthly subcutaneous injection, showing no evidence for the need for post-injection monitoring, which is typically required for other formulations.The acceptance of this NDA marks a significant milestone for Teva as it seeks to provide a long-acting option for patients who rely on olanzapine.TEV-‘749 utilizes SteadyTeq, a copolymer technology proprietary to Medincell that provides a controlled, steady, su","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/23/Brain-to-Heart-Growth.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/23/Brain-to-Heart-Growth.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/fda/26/02/50777798/fda-accepts-tevas-new-long-acting-schizophrenia-treatment-application","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/26/02/50777798/fda-accepts-tevas-new-long-acting-schizophrenia-treatment-application","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4584","TEVA","BK4596","BK4566","BK4588","BK4007","LU1983299246.USD","BK4585","BK4217","BK4559","BK4557","LU2324357040.USD","SMA"],"gpt_icon":0},{"id":"2613978903","title":"Harrow (HROW) Valuation Check As PharmaPack Launch Targets Cataract Surgery Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2613978903","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613978903?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:30","pubTimestamp":1771846210,"startTime":"0","endTime":"0","summary":"PharmaPack launch puts Harrow stock in focus\nHarrow (HROW) has drawn fresh attention after launching PharmaPack, a direct-to-prescriber cash-pay program offering FDA-approved ophthalmic kits intended to replace off-label compounded products used around cataract surgery.\nSee our latest analysis for Harrow.\nThe PharmaPack announcement comes as Harrow’s short term share price momentum is strong, with a 1 month share price return of 16.93% and a 90 day share price return of 26.77%, set against a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrow/harrow/news/harrow-hrow-valuation-check-as-pharmapack-launch-targets-cat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrow/harrow/news/harrow-hrow-valuation-check-as-pharmapack-launch-targets-cat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4557","HROW","BK4007"],"gpt_icon":0},{"id":"2613100788","title":"Aurora UK Alpha Affirms MAR Compliance and Trading Ability in Closed Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2613100788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613100788?lang=en_us&edition=fundamental","pubTime":"2026-02-23 17:17","pubTimestamp":1771838243,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aurora Investment Trust PLC ( ($GB:ARR) ). Aurora UK Alpha plc has confirmed its compliance with Market Abuse R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-affirms-mar-compliance-and-trading-ability-in-closed-period?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-affirms-mar-compliance-and-trading-ability-in-closed-period?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BD0PCF45.HKD","LU1718418525.SGD","LU0690374961.EUR","ABIL","LU2404859667.USD","GB00B4QBRK32.GBP","IE00B95QR487.USD","MAR","ACB","IE00B1G9WX41.USD","IE00B0T0GQ85.USD","MSOS","BK4007","BK4557","BK4588","LU2404859741.USD","IE00B45NX917.SGD","LU0690374615.EUR","GB00B4LPDJ14.GBP","BK4142","BK4585"],"gpt_icon":0},{"id":"2613207683","title":"Nelson Resources Relocates Registered Office to Perth CBD","url":"https://stock-news.laohu8.com/highlight/detail?id=2613207683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613207683?lang=en_us&edition=fundamental","pubTime":"2026-02-23 15:59","pubTimestamp":1771833547,"startTime":"0","endTime":"0","summary":"Nelson Resources Ltd. ( ($AU:NES) ) has issued an announcement. Nelson Resources Limited has announced a change to its registered and principal pla...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nelson-resources-relocates-registered-office-to-perth-cbd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nelson-resources-relocates-registered-office-to-perth-cbd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4113","BK4007","CBD","ACB","MSOS","BK4557"],"gpt_icon":0},{"id":"2613829408","title":"Teva Pharmaceutical Says FDA Accepts New Drug Application for Olanzapine in Schizophrenia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2613829408","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613829408?lang=en_us&edition=fundamental","pubTime":"2026-02-21 04:05","pubTimestamp":1771617940,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said Friday that the US Food and Drug Administration has accepted the company's New Drug Application for olanzapine extended-release injectable suspension, or TEV-'749, for the treatment of schizophrenia in adults.The application for TEV-'749 is based on results from the phase 3 Solaris trial that demonstrated an efficacy and safety profile consistent with other available olanzapine formulations, and showed no evidence for the need for post-injection monitoring, Teva Pharmaceutical Industries said.Shares of the company were down over 1% in recent Friday trading.Price: 34.00, Change: -0.33, Percent Change: -0.96","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU2324357040.USD","BK4584","BK4596","BK4585","BK4557","BK4588","BK4559","LU1983299246.USD","TEVA","BK4566"],"gpt_icon":0},{"id":"2613129475","title":"FDA accepts Teva NDA for olanzapine extended-release injectable suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2613129475","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613129475?lang=en_us&edition=fundamental","pubTime":"2026-02-21 03:55","pubTimestamp":1771617319,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Medincell announced that the U.S. Food and Drug Administr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-accepts-teva-nda-for-olanzapine-extended-release-injectable-suspension-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-accepts-teva-nda-for-olanzapine-extended-release-injectable-suspension-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4566","BK4557","BK4588","BK4585","TEVA","LU2324357040.USD","BK4559","BK4007","LU1983299246.USD","BK4584"],"gpt_icon":0},{"id":"2613295236","title":"Dr. Reddy's Secures FDA Review for Abatacept Biologics License Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2613295236","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613295236?lang=en_us&edition=fundamental","pubTime":"2026-02-21 00:29","pubTimestamp":1771604952,"startTime":"0","endTime":"0","summary":"Dr. Reddy's Laboratories (RDY) said Friday the US Food and Drug Administration has accepted for review its biologics license application for an IV infusion formulation of DRL_AB, a proposed biosimilar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK7016","BK4523","BK4007","RDY","LU0348744763.USD","RDY.AU","BK4557","BK4596"],"gpt_icon":0},{"id":"2612416298","title":"Aurora Innovation Years Ahead of Competitors, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2612416298","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612416298?lang=en_us&edition=fundamental","pubTime":"2026-02-20 23:06","pubTimestamp":1771600001,"startTime":"0","endTime":"0","summary":"Aurora Innovation  is years ahead of is competitors in creating fully self-driving on-road commercial vehicles, Oppenheimer analysts said in a note to clients Friday.\"We are encouraged by the efficiency of its technology foundation, which is enabling rapid Operating Design Domain expansion leveraging on-road experience and simulation capabilities,\" the analysts wrote.Oppenheimer said demand for the company's vehicles remains strong, and exceeds its planned production schedule. It also estimates savings of approximately 15% of driver expense, and fuel savings of 14% to 34%.\"It appears that AUR's unit economics would put non-automated carriers at a significant disadvantage which should further drive adoption,\" the analysts wrote.Price: 4.82, Change: -0.04, Percent Change: -0.93","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK4127","AUR.AU","BK4137","OPY","BK4007","ACB","BK4557","MSOS","AUR","BK7095"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":100,"code":"91000000","status":"200"}]}}